MedPath

A Study to Analyze the Effects of Exparel for Post-Surgery Pain Control in Patients Undergoing Penile Prosthesis Placement

Phase 4
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Randomization of two local anesthetics.
Registration Number
NCT04801368
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this research is to determine the effects of penile ring block for local anesthesia with liposomal bupivacaine vs ropivacaine mixture in subjects undergoing surgery for Penile Prosthesis Placement.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • Men undergoing 3-piece penile prosthesis placement under general anesthesia at Mayo Clinic - Rochester.
  • ≥ 18 years old.

Exclusion Citeria:

  • History of opioid exposure within the preceding 90 days prior to surgery (based on patient-report, review of the electronic medical record, and NMP prescribing database review)
  • Current or prior history of alcohol or drug abuse (illicit or prescription)
  • History of chronic pain conditions (chronic musculoskeletal pain, fibromyalgia, central sensitization, chronic pelvic pain syndrome, etc.)
  • History of cardiac arrhythmia or untreated severe cardiovascular disease
  • Uncontrolled hypertension
  • Hepatic insufficiency
  • Renal insufficiency (CKD stage IIIa or greater)
  • Current anti-platelet or anti-coagulation therapy with plans to continue at the time of prosthesis placement
  • Poorly controlled diabetes mellitus (defined as HgbA1c > 8.5 within 30 days of surgery)
  • Concurrent adjunctive operative procedures planned at the time of penile prosthesis placement (examples: male urethral sling, Peyronie's disease straightening with penile plication or incision/grafting)
  • Concurrent non-prosthetic surgery planned at the time of penile prosthesis placement (examples: circumcision, hernia repair, hydrocelectomy, etc.)
  • Planned infrapubic or subcoronal incision at the time of penile prosthesis placement
  • Patients who will be undergoing prosthesis placement using local, monitored, or spinal anesthesia (i.e. non-general anesthesia)
  • Allergy or history of intolerance to any local anesthetic agents included in the protocol
  • History of prior penile prosthesis or artificial urinary sphincter surgery
  • Revision penile prosthesis surgery
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Receiving Liposomal BupivacaineRandomization of two local anesthetics.Patients receiving Liposomal Bupivacaine.
Receiving RopivacaineRandomization of two local anesthetics.Patients receiving Ropivacaine.
Primary Outcome Measures
NameTimeMethod
State Trait Anxiety Inventorypost-operative day 14

Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.

Visual-analogue pain scalepost-operative day 14

Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.

Visual-analogue anxiety scalepost-operative day 14

Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.

Pain Catastrophizing scalepost-operative day 14

Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath